To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,771 · see citing works

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565 · see citing works

Stimuli-responsive nanocarriers for drug delivery

Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289 · see citing works

Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy

Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · see citing works

Doxil® — The first FDA-approved nano-drug: Lessons learned

Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · see citing works

Diffusion of univalent ions across the lamellae of swollen phospholipids

Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · see citing works

Nanoparticle therapeutics: an emerging treatment modality for cancer

Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233 · see citing works

Strategies in the design of nanoparticles for therapeutic applications

Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651 · see citing works

The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect

Fang, J. Q., Nakamura, H., & Maeda, H. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,573 · see citing works

Delivering nanomedicine to solid tumors

Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,196 · see citing works

To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery

Danhier, F., Féron, O., & Véronique Préat, A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,827 · see citing works

Drug penetration in solid tumours

Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805 · see citing works

Shape effects of filaments versus spherical particles in flow and drug delivery

Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565 · see citing works

High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy

Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222 · see citing works

Polymer conjugates as anticancer nanomedicines

Duncan, R. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1958 · Cited by 1,956 · see citing works

Basement membranes: structure, assembly and role in tumour angiogenesis

Kalluri, R. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1094 · Cited by 1,748 · see citing works

Changing views of the role of matrix metalloproteinases in metastasis

Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,576 · see citing works

Nanocarriers’ entry into the cell: relevance to drug delivery

Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,549 · see citing works

Transport of molecules in the tumor interstitium: a review.

Jain, R. K. (1987) · PubMed · Cited by 1,357 · see citing works

Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress

Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324 · see citing works

Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer

Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,317 · see citing works

Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles

Verma, A., Uzun, O., Hu, Y., Hu, Y., Han, H., Watson, N., Chen, S., Irvine, D. J., & Stellacci, F. (2008) · Nature Materials · doi:10.1038/nmat2202 · Cited by 1,268 · see citing works

Challenges and strategies in anti-cancer nanomedicine development: An industry perspective

Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,246 · see citing works

Tumors as Organs: Complex Tissues that Interface with the Entire Organism

Egeblad, M., Nakasone, E. S., & Werb, Z. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.012 · Cited by 1,230 · see citing works

Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan

Gordon, A. N., Fleagle, J., Guthrie, D., Parkin, D. E., Gore, M. E., & Lacave, Á. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.14.3312 · Cited by 1,212 · see citing works

Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors

Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189 · see citing works

Polymers for the sustained release of proteins and other macromolecules

LANGER, R., & FOLKMAN, J. (1976) · Nature · doi:10.1038/263797a0 · Cited by 1,182 · see citing works

Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity

Maeda, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.002 · Cited by 1,179 · see citing works

Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile

Hrkach, J. S., Hoff, D. D. V., Ali, M. M., Andrianova, E. A., Auer, J., Campbell, T., Witt, D. D., Figa, M. A., Figueiredo, M., Horhota, A. T., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003651 · Cited by 1,147 · see citing works

Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors

Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Girard, O. M., Hanahan, D., Mattrey, R. F., & Ruoslahti, E. I. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.013 · Cited by 1,140 · see citing works

Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs

Sugahara, K. N., Teesalu, T., Karmali, P. P., Kotamraju, V. R., Agemy, L., Greenwald, D. R., & Ruoslahti, E. I. (2010) · Science · doi:10.1126/science.1183057 · Cited by 1,080 · see citing works

The Smart Drug Delivery System and Its Clinical Potential

Liu, D., Yang, F., Xiong, F., & Gu, N. (2016) · Theranostics · doi:10.7150/thno.14858 · Cited by 1,066 · see citing works

RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis

Danhier, F., Breton, A. L., & Véronique Préat, A. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002733 · Cited by 959 · see citing works

Locoregional cancer treatment with magnetic drug targeting.

Alexiou, C., Arnold, W. J., Klein, R. J., Parak, F., Hulin, P., Bergemann, C., Erhardt, W. D., Wagenpfeil, S., & Lübbe, A. S. (2000) · PubMed · Cited by 863 · see citing works

EPR: Evidence and fallacy

Nichols, J. W., & Bae, Y. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.057 · Cited by 834 · see citing works

Delivery of molecular and cellular medicine to solid tumors

Jain, R. K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.011 · Cited by 775 · see citing works

Large unilamellar liposomes with low uptake into the reticuloendothelial system

Allen, T. M., & Chonn, A. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80506-9 · Cited by 729 · see citing works

Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.

Lee, C. G., Heijn, M., di Tomaso, E., Griffon, G., Ancukiewicz, M., Koike, C., Park, K. R., Ferrara, N., Jain, R. K., Suit, H. D., et al. (2000) · PubMed · Cited by 674 · see citing works

Role of tumor–host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors

Pluen, A., Boucher, Y., Ramanujan, S., McKee, T. D., Gohongi, T., di Tomaso, E., Brown, E. B., Izumi, Y., Campbell, R. B., Berk, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081626898 · Cited by 604 · see citing works

Injectable hydrogel-based drug delivery systems for local cancer therapy

Norouzi, M., Nazari, B., & Miller, D. W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.07.006 · Cited by 565 · see citing works

Development of TGF-β signalling inhibitors for cancer therapy

Yingling, J. M., Blanchard, K. L., & Sawyer, J. S. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1580 · Cited by 550 · see citing works

Improving drug delivery to solid tumors: Priming the tumor microenvironment

Khawar, I. A., Kim, J. H., & Kuh, H.-J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.018 · Cited by 533 · see citing works

Delivery of molecular and cellular medicine to solid tumors1PII of original article: S0169-409X(97)00027-6. The article was originally published in Advanced Drug Delivery Reviews 26 (1997) 71–90.1

Jain, R. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00131-9 · Cited by 529 · see citing works

Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol)

Sparreboom, A., Scripture, C. D., Trieu, V. N., Williams, P. J., De, T., Yang, A. J., Beals, B., Figg, W. D., Hawkins, M., & Desai, N. P. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2291 · Cited by 506 · see citing works

Applications of nanoparticles for diagnosis and therapy of cancer

Baetke, S. C., Lammers, T., & Kiessling, F. M. (2015) · British Journal of Radiology · doi:10.1259/bjr.20150207 · Cited by 499 · see citing works

Matrix Metalloprotease 2-Responsive Multifunctional Liposomal Nanocarrier for Enhanced Tumor Targeting

Zhu, L., Kate, P., & Torchilin, V. P. (2012) · ACS Nano · doi:10.1021/nn300524f · Cited by 496 · see citing works

Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration

Chauhan, V. P., Popović, Z., Chen, O., Cui, J., Fukumura, D., Bawendi, M. G., & Jain, R. K. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201104449 · Cited by 474 · see citing works

Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges

Laurent, S., Saei, A. A., Behzadi, S., Panahifar, A., & Mahmoudi, M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.924501 · Cited by 445 · see citing works

Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA

Zuckerman, J. E., Gritli, I., Tolcher, A. W., Heidel, J. D., Lim, D. W., Morgan, R. J., Chmielowski, B., Ribas, A., Davis, M. E., & Yen, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411393111 · Cited by 436 · see citing works

p H-Sensitive Liposomes: Possible Clinical Implications

Yatvin, M. B., Kreutz, W., Horwitz, B. A., & Shinitzky, M. (1980) · Science · doi:10.1126/science.7434025 · Cited by 415 · see citing works

Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling

Kano, M. R., Bae, Y., Iwata, C., Morishita, Y., Yashiro, M., Oka, M., Fujii, T., Komuro, A., Kiyono, K., Kaminishi, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611660104 · Cited by 410 · see citing works

Theranostic applications of nanoparticles in cancer

Ahmed, N., Fessi, H., & Elaı̈ssari, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.010 · Cited by 409 · see citing works

Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures

Ragelle, H., Danhier, F., Véronique Préat, A., Langer, R., & Anderson, D. G. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1244187 · Cited by 392 · see citing works

Odyssey of a cancer nanoparticle: From injection site to site of action

Nichols, J. W., & Bae, Y. H. (2012) · Nano Today · doi:10.1016/j.nantod.2012.10.010 · Cited by 364 · see citing works

Untitled work

(1999) · PubMed · Cited by 348 · see citing works

Does a targeting ligand influence nanoparticle tumor localization or uptake?

Pirollo, K. F., & Chang, E. H. (2008) · Trends in biotechnology · doi:10.1016/j.tibtech.2008.06.007 · Cited by 347 · see citing works

Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications

Rizzo, L. Y., Theek, B., Storm, G., Kiessling, F. M., & Lammers, T. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.02.020 · Cited by 340 · see citing works

Barriers to drug delivery in solid tumors

Sriraman, S. K., Aryasomayajula, B., & Torchilin, V. P. (2014) · Tissue Barriers · doi:10.4161/tisb.29528 · Cited by 338 · see citing works

Focused ultrasound-mediated drug delivery through the blood–brain barrier

Burgess, A., Shah, K., Hough, O., & Hynynen, K. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1028369 · Cited by 325 · see citing works

Increased nanoparticle penetration in collagenase-treated multicellular spheroids.

Goodman, T. T., Olive, P. L., & Pun, S. H. (2007) · PubMed Central · Cited by 302 · see citing works

Design considerations for nanotherapeutics in oncology

Stylianopoulos, T., & Jain, R. K. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.07.015 · Cited by 284 · see citing works

Causes and Effects of Heterogeneous Perfusion in Tumors

Gillies, R. J., Schomack, P. A., Secomb, T. W., & Raghunand, N. (1999) · Neoplasia · doi:10.1038/sj.neo.7900037 · Cited by 283 · see citing works

Macromolecular Therapeutics

Greish, K. F., Fang, J. Q., Inutsuka, T., Nagamitsu, A., & Maeda, H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00002 · Cited by 277 · see citing works

High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents

Polyak, B., Fishbein, I., Chorny, M., Alferiev, I., Williams, D., Yellen, B., Friedman, G., & Levy, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708338105 · Cited by 257 · see citing works

Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer

Matsumura, Y., Gotoh, M., Muro, K., Yamada, Y., Shirao, K., Shimada, Y., Okuwa, M., Matsumoto, S., Miyata, Y., Ohkura, H., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh092 · Cited by 253 · see citing works

Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art

Karim, R., Palazzo, C., Évrard, B., & Piel, G. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.026 · Cited by 253 · see citing works

Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study

Mamot, C., Ritschard, R., WICKI, A. N., Stehle, G., Dieterle, T., Bubendorf, L., Hilker, C., Deuster, S., Herrmann, R., & Rochlitz, C. F. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70476-x · Cited by 244 · see citing works

Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment

Casazza, A., Conza, G. D., Wenes, M., Finisguerra, V., Deschoemaeker, S., & Mazzone, M. (2013) · Oncogene · doi:10.1038/onc.2013.121 · Cited by 243 · see citing works

Cycling hypoxia: A key feature of the tumor microenvironment

Michiels, C., Tellier, C., & Féron, O. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.06.004 · Cited by 239 · see citing works

Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy

Schleich, N., Po, C., Jacobs, D., Ucakar, B., Gallez, B., Danhier, F., & Préat, V. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.059 · Cited by 238 · see citing works

Nanoparticles for Imaging: top or Flop?

Kiessling, F., Mertens, M. E., Grimm, J., & Lammers, T. (2014) · Radiology · doi:10.1148/radiol.14131520 · Cited by 228 · see citing works

Hyaluronidase induces a transcapillary pressure gradient and improves the distribution and uptake of liposomal doxorubicin (Caelyx™) in human osteosarcoma xenografts

Eikenes, L., Tari, M., Tufto, I., Bruland, Ø. S., & de Lange Davies, C. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602626 · Cited by 221 · see citing works

Enhanced Vascular Permeability in Solid Tumor Is Mediated by Nitric Oxide and Inhibited by Both New Nitric Oxide Scavenger and Nitric Oxide Synthase Inhibitor

Maeda, H., Noguchi, Y., Sato, K., & Akaike, T. (1994) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1994.tb02362.x · Cited by 221 · see citing works

Personalized Nanomedicine

Lammers, T., Rizzo, L. Y., Storm, G., & Kiessling, F. M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1414 · Cited by 195 · see citing works

Biomaterial-based regional chemotherapy: Local anticancer drug delivery to enhance chemotherapy and minimize its side-effects

Krukiewicz, K., & Żak, J. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.01.063 · Cited by 194 · see citing works

Paclitaxel Decreases the Interstitial Fluid Pressure and Improves Oxygenation in Breast Cancers in Patients Treated With Neoadjuvant Chemotherapy: Clinical Implications

Taghian, A. G., Abi-Raad, R. F., Assaad, S. I., Casty, A., Ancukiewicz, M., Yeh, E. D., Molokhia, P., Attia, K., Sullivan, T., Kuter, I., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.119 · Cited by 192 · see citing works

Two-photon fluorescence correlation microscopy reveals the two-phase nature of transport in tumors

Alexandrakis, G., Brown, E. B., Tong, R. T., McKee, T. D., Campbell, R. B., Boucher, Y., & Jain, R. K. (2004) · Nature Medicine · doi:10.1038/nm981 · Cited by 178 · see citing works

Thalidomide Radiosensitizes Tumors through Early Changes in the Tumor Microenvironment

Ansiaux, R., Baudelet, C., Jordan, B. F., Beghein, N., Sonveaux, P., Wever, J. D., Martinive, P., Grégoire, V., Féron, O., & Gallez, B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.743.11.2 · Cited by 163 · see citing works

A LIPOPHILIC DERIVATIVE OF NEOCARZINOSTATIN A Polymer Conjugation of an Antitumor Protein Antibiotic*

MAEDA, H., Takeshita, J., & Kanamaru, R. (1979) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1979.tb01730.x · Cited by 157 · see citing works

Exploring the Tumor Microenvironment with Nanoparticles

Miao, L., & Huang, L. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-16555-4_9 · Cited by 154 · see citing works

Assembly, heterogeneity, and breaching of the basement membranes

Glentis, A., Gurchenkov, V., & Vignjevic, D. M. (2014) · Cell Adhesion & Migration · doi:10.4161/cam.28733 · Cited by 132 · see citing works

Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma

Bastiancich, C., Vanvarenberg, K., Učakar, B., Pitorre, M., Bastiat, G., Lagarce, F., Véronique Préat, A., & Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.054 · Cited by 129 · see citing works

Iron oxide-loaded nanotheranostics: major obstacles to in vivo studies and clinical translation

Schleich, N., Danhier, F., & Préat, V. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.11.024 · Cited by 124 · see citing works

Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems

Lammers, T., Peschke, P., Kühnlein, R., Subr, V., Ulbrich, K., Debus, J., Huber, P., Hennink, W., & Storm, G. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.032 · Cited by 124 · see citing works

High Intratumoral Accumulation of Stealth Liposomal Doxorubicin in Sarcomas: Rationale for Combination with Radiotherapy

Koukouraki, A. M. I. K. S. (2000) · Acta Oncologica · doi:10.1080/028418600430789 · Cited by 122 · see citing works

Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor‐β receptor inhibitor on extravasation of nanoparticles from neovasculature

Kano, M. R., Komuta, Y., Iwata, C., Oka, M., Shirai, Y.-T., Morishita, Y., Ouchi, Y., Kataoka, K., & Miyazono, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.01003.x · Cited by 121 · see citing works

Lowering of tumor interstitial fluid pressure specifically augments efficacy of chemotherapy

Salnikov, A. V., Iversen, V. V., Koisti, M. J., Sundberg, C., Johansson, L. O. M., Stuhr, L. E. B., Sjöquist, M., Ahlström, H. K., Reed, R. K., & Rubin, K. (2003) · The FASEB Journal · doi:10.1096/fj.02-1201fje · Cited by 116 · see citing works

Tumor Angiogenesis: Insights and Innovations

Nussenbaum, F., & Herman, I. M. (2010) · Journal of Oncology · doi:10.1155/2010/132641 · Cited by 115 · see citing works

Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy

Henderson, I. C., & Bhatia, V. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.7.919 · Cited by 102 · see citing works

Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro

Masterson, R., Hewitson, T. D., Kelynack, K. J., Martic, M., Parry, L. J., Bathgate, R. A. D., Darby, I. A., & Becker, G. J. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg598 · Cited by 100 · see citing works

Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery

Bouzin, C., & Féron, O. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.03.001 · Cited by 96 · see citing works

Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment

Yokoi, K., Kojic, M., Milosevic, M., Tanei, T., Ferrari, M., & Ziemys, A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3494 · Cited by 95 · see citing works

Enhancement of Paclitaxel Delivery to Solid Tumors by Apoptosis-Inducing Pretreatment: Effect of Treatment Schedule

Jang, S. H., Wientjes, M. G., & Au, J. L. ‐. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38848-2 · Cited by 93 · see citing works

Effects of steroids and nonsteroid anti-inflammatory agents on vascular permeability in a rat glioma model

Reichman, H. R., Farrell, C. L., & Maestro, R. F. D. (1986) · Journal of neurosurgery · doi:10.3171/jns.1986.65.2.0233 · Cited by 92 · see citing works

Improving Delivery and Efficacy of Nanomedicines in Solid Tumors: Role of Tumor Priming

Wang, J., Lu, Z., Gao, Y., Wientjes, M. G., & Au, J. L. ‐. (2011) · Nanomedicine · doi:10.2217/nnm.11.141 · Cited by 85 · see citing works

Kallikrein–kinin in infection and cancer

Maeda, H., Wu, J., Okamoto, T., Maruo, K., & Akaike, T. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00104-6 · Cited by 83 · see citing works

Nanomedicines Targeting the Tumor Microenvironment

Tong, R., & Langer, R. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000123 · Cited by 80 · see citing works

Potentiation of cyclophosphamide chemotherapy using the anti-angiogenic drug thalidomide: Importance of optimal scheduling to exploit the ‘normalization’ window of the tumor vasculature

Segers, J., Fazio, V. D., Ansiaux, R., Martinive, P., Féron, O., Wallemacq, P. E., & Gallez, B. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.12.017 · Cited by 78 · see citing works

Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for Paclitaxel

Danhier, F., Magotteaux, N., Učakar, B., Lecouturier, N., Brewster, M. E., & Véronique Préat, A. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.015 · Cited by 67 · see citing works

Paclitaxel-loaded micelles enhance transvascular permeability and retention of nanomedicines in tumors

Danhier, F., Danhier, P., Saedeleer, C. J. D., Fruytier, A., Schleich, N., Rieux, A. D., Sonveaux, P., Gallez, B., & Véronique Préat, A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.01.009 · Cited by 67 · see citing works

Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.

Kuriyama, N., Kuriyama, H., Julin, C. M., et al. (2001) · PubMed · Cited by 59 · see citing works

The pathway to commercialization for nanomedicine

Flynn, T., & Wei, C. (2005) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2004.11.010 · Cited by 57 · see citing works

Multistage Nanoparticles for Improved Delivery into Tumor Tissue

Stylianopoulos, T., Wong, C., Bawendi, M. G., Jain, R. K., & Fukumura, D. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391860-4.00006-9 · Cited by 50 · see citing works

Technology evaluation: bevacizumab, Genentech/Roche.

Salgaller, M. L. (2003) · PubMed · Cited by 42 · see citing works

Metalloproteinase‐9 is increased after toluene diisocyanate exposure in the induced sputum from patients with toluene diisocyanate‐induced asthma

Park, H., Kim, H., Jung, J. ‐., et al. (2003) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2003.01563.x · Cited by 37 · see citing works

Electron Paramagnetic Resonance Highlights That the Oxygen Effect Contributes to the Radiosensitizing Effect of Paclitaxel

Danhier, F., Danhier, P., Magotteaux, N., Preter, G. D., Učakar, B., Karroum, O., Jordan, B. F., Gallez, B., & Véronique Préat, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040772 · Cited by 22 · see citing works

Strategies to improve the EPR effect for the delivery of anti-cancer nanomedicines

Danhier, F., & Véronique Préat, A. (2015) · Cancer Cell & Microenvironment · doi:10.14800/ccm.808 · Cited by 20 · see citing works

Sports Medicine and the Americans with Disabilities Act

Nichols, A. W. (1996) · Clinical Journal of Sport Medicine · doi:10.1097/00042752-199607000-00009 · Cited by 8 · see citing works

Clinical development and potential of photothermal and photodynamic therapies for cancer

Li, X., Lovell, J. F., Yoon, J., & Chen, X. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0410-2 · Cited by 3,456 · see citing works

The entry of nanoparticles into solid tumours

Sindhwani, S., Syed, A. M., Ngai, J., Kingston, B. R., Maiorino, L., Rothschild, J., MacMillan, P., Zhang, Y., Rajesh, N. U., Hoang, T., et al. (2020) · Nature Materials · doi:10.1038/s41563-019-0566-2 · Cited by 1,732 · see citing works

Tumor targeting via EPR: Strategies to enhance patient responses

Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262 · see citing works

Targeting Tumor Microenvironment for Cancer Therapy

Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040840 · Cited by 1,187 · see citing works

The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application

Wu, J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11080771 · Cited by 1,030 · see citing works

Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment

Subhan, M. A., Yalamarty, S. S. K., Filipczak, N., Parveen, F., & Torchilin, V. P. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060571 · Cited by 623 · see citing works

A Perspective on Polylactic Acid-Based Polymers Use for Nanoparticles Synthesis and Applications

Casalini, T., Rossi, F., Castrovinci, A., & Perale, G. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00259 · Cited by 500 · see citing works

Biological Utility of Fluorinated Compounds: From Materials Design to Molecular Imaging, Therapeutics and Environmental Remediation

Zhang, C., Yan, K., Fu, C., Peng, H., Hawker, C. J., & Whittaker, A. K. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00632 · Cited by 493 · see citing works

Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms

Zi, Y., Yang, K., He, J., Wu, Z., Liu, J., & Zhang, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114449 · Cited by 268 · see citing works

Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis

Liu, R., Xiao, W., Hu, C., Xie, R., & Gao, H. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.005 · Cited by 250 · see citing works

Nanodrug Delivery Systems Modulate Tumor Vessels to Increase the Enhanced Permeability and Retention Effect

Huang, D., Sun, L., Huang, L., & Chen, Y. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020124 · Cited by 176 · see citing works

Application of 3D cultured multicellular spheroid tumor models in tumor-targeted drug delivery system research

Huang, B.-W., & Gao, J.-Q. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.005 · Cited by 174 · see citing works

Combination therapy based on nano codelivery for overcoming cancer drug resistance

Wang, H., & Huang, Y. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100024 · Cited by 115 · see citing works

A Biomimetic Microfluidic Tumor Microenvironment Platform Mimicking the EPR Effect for Rapid Screening of Drug Delivery Systems

Tang, Y., Soroush, F., Sheffield, J. B., Wang, B., Prabhakarpandian, B., & Kiani, M. F. (2017) · Scientific Reports · doi:10.1038/s41598-017-09815-9 · Cited by 102 · see citing works

Chemotherapeutic drug delivery by tumoral extracellular matrix targeting

Raavé, R., van Kuppevelt, T. H., & Daamen, W. F. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.01.029 · Cited by 106 · see citing works

Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis

Subhan, M. A., Parveen, F., Filipczak, N., Yalamarty, S. S. K., & Torchilin, V. P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030389 · Cited by 98 · see citing works

Ultrabright Fluorescent Polymeric Nanoparticles with a Stealth Pluronic Shell for Live Tracking in the Mouse Brain

Khalin, I., Heimburger, D., Melnychuk, N., Collot, M., Groschup, B., Hellal, F., Reisch, A., Plesnila, N., & Klymchenko, A. S. (2020) · ACS Nano · doi:10.1021/acsnano.0c01505 · Cited by 82 · see citing works

Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy

Muntimadugu, E., Kommineni, N., & Khan, W. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.010 · Cited by 82 · see citing works

Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment

de Maar, J. S., Sofias, A. M., Porta Siegel, T., Vreeken, R. J., Moonen, C., Bos, C., & Deckers, R. (2020) · Theranostics · doi:10.7150/thno.38625 · Cited by 71 · see citing works

Thinking about Enhanced Permeability and Retention Effect (EPR)

Leporatti, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12081259 · Cited by 58 · see citing works

Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles

Mehta, A., Dalle Vedove, E., Isert, L., & Merkel, O. M. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2665-9 · Cited by 53 · see citing works

Gold Nanoparticle Aggregates Functionalized with Cyclic RGD Peptides for Targeting and Imaging of Colorectal Cancer Cells

Biscaglia, F., Ripani, G., Rajendran, S., Benna, C., Mocellin, S., Bocchinfuso, G., Meneghetti, M., Palleschi, A., & Gobbo, M. (2019) · ACS Applied Nano Materials · doi:10.1021/acsanm.9b01392 · Cited by 54 · see citing works

Implantable, 3D-Printed Alginate Scaffolds with Bismuth Sulfide Nanoparticles for the Treatment of Local Breast Cancer via Enhanced Radiotherapy

Colak, B., & Ertas, Y. N. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c17024 · Cited by 50 · see citing works

Low frequency nanobubble-enhanced ultrasound mechanotherapy for noninvasive cancer surgery

Bismuth, M., Katz, S., Mano, T., Aronovich, R., Hershkovitz, D., Exner, A. A., & Ilovitsh, T. (2022) · Nanoscale · doi:10.1039/d2nr01367c · Cited by 40 · see citing works

PExy: The Other Side of Exploit Kits

Maio, G. D., Kapravelos, A., Shoshitaishvili, Y., et al. (2014) · Lecture notes in computer science · doi:10.1007/978-3-319-08509-8_8 · Cited by 24 · see citing works

AEMB: An Automated Exploit Mitigation Bypassing Solution

Wang, R., Pan, Z., Shi, F., et al. (2021) · Applied Sciences · doi:10.3390/app11209727 · Cited by 4 · see citing works

AEG: Automatic Exploit Generation

(2018) · doi:10.1184/r1/6468296.v1 · Cited by 205 · see citing works

Evaluation of Two Host-Based Intrusion Prevention Systems

Labbe, K. G. (2005) · Defense Technical Information Center (DTIC) · Cited by 1 · see citing works

Automated Crash Analysis and Exploit Generation with Extendable Exploit Model

Liu, Z., Wang, Z., Zhang, Y., et al. (2022) · IEEE International Conference on Data Science in Cyberspace · doi:10.1109/dsc55868.2022.00017 · Cited by 4 · see citing works